Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression
Lobna Ibrahim, Nancy Diazgranados, David A Luckenbaugh, Rodrigo Machado-Vieira, Jacqueline Baumann, Alan G Mallinger, Carlos A Zarate Jr, Lobna Ibrahim, Nancy Diazgranados, David A Luckenbaugh, Rodrigo Machado-Vieira, Jacqueline Baumann, Alan G Mallinger, Carlos A Zarate Jr
Abstract
Background: Ketamine rapidly improves depressive symptoms in patients with treatment-resistant major depressive disorder (MDD) who do not respond to multiple standard antidepressants. However, it remains unknown whether ketamine is equally effective in patients with MDD who previously also did not respond to electroconvulsive therapy (ECT).
Methods: This study compared 17 patients with treatment-resistant MDD who previously did not respond to ECT and 23 patients with treatment-resistant MDD who had not previously received ECT. All subjects received a single open-label infusion of ketamine (0.5 mg/kg). Patients were evaluated using the Montgomery-Asberg Depression Rating Scale (MADRS) at baseline (60 min before the infusion), as well as at 40, 80, 120, and 230 min after infusion.
Results: Depressive symptoms were significantly improved in the ECT-resistant group at 230 minutes with a moderate effect size (p < .001, d = 0.50, 95% C.I.: 0.21-0.80). At 230 minutes, the non-ECT exposed group showed significant improvement with a large effect size (p < .001, d=1.00, 95% C.I.: 0.71-1.29).
Conclusion: Ketamine appears to improve depressive symptoms in patients with MDD who had previously not responded to ECT. These preliminary results encourage further investigation with a larger sample size to determine effectiveness compared to other treatment-resistant patients with MDD.
Published by Elsevier Inc.
Figures


Source: PubMed
Próximos ensayos clínicos
-
October University for Modern Sciences and ArtsReclutamiento
-
Uskudar UniversityAún no reclutandoDolor musculoesquelético | Enfermedades ProfesionalesTurquía (Türkiye)
-
Milton S. Hershey Medical CenterAxogen CorporationAún no reclutandoCáncer de parótida | Parotidectomía | Síndrome de Frey | Parotidectomía, resultados informados por el paciente | Tumor de la glándula parótida
-
University of the Italian SwitzerlandUniversita di VeronaAún no reclutandoCarga del cuidador | Trastorno sicologicoSuiza
-
Ain Shams UniversityAún no reclutandoHip Abductor Insufficiency Following Total Hip Arthroplasty
-
University of CalgaryAún no reclutandoHipospadias | Obstrucción de la unión ureteropélvicaCanadá
-
Reinovax Biologics Co., LTDAún no reclutandoA Phase Ⅲ Clinical Trial of an Investigative 24-valent Pneumococcal Polysaccharide Conjugate VaccineEnfermedad infecciosa neumocócicaPorcelana
-
Research IncReclutamientoPostoperative Nasal Fibrosis After RhinoplastyColombia
-
Abramson Cancer Center at Penn MedicineAún no reclutando
-
Aligos TherapeuticsAún no reclutandoParticipantes SaludablesEstados Unidos
-
PT Equilab InternationalNestle IndonesiaReclutamiento
-
Stanford UniversityAún no reclutando